Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica

Z. Rehak, J. Vasina, P. Nemec, Z. Fojtik, R. Koukalova, Z. Bortlicek, D. Rehakova, J. Adam, A. Vavrusova, Z. Adam

. 2015 ; 159 (4) : 629-636. [pub] 20150525

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17004322

AIM: Polymyalgia rheumatica (PMR) is a disease presenting with pain and stiffness, mainly in shoulders, hip joints and neck. Laboratory markers of inflammation may bolster diagnosis. PMR afflicts patients over 50 years old, predominantly women, and may also accompany giant cell arteritis. PATIENTS AND METHODS: 67 patients, who fullfiled Healey´s criteria for PMR in the period between 2004 and 2013 and had positive FDG PET (PET/CT) findings were retrospectively evaluated. FDG uptake was assessed in large arteries, proximal joints (shoulders, hips and sternoclavicular joints), in extraarticular synovial structures (interspinous, ischiogluteal and praepubic bursae). RESULTS: Articular/periarticular involvement (A) was detected in 59/67 (88.1%) patients and extrarticular synovial involvement (E) in 51/67 (76.1%) patients either individually or in combinations. Vascular involvement (V) was detected in 27/67 (40.3%) patients only in combination with articular (A) and/or extraarticular synovial (E) involvement. These combinations were: A+E involvement in 30/67 (44.8%) patients, A+V involvement in 8/67 (11.9%) patients, E+V involvement in 6/67 (9%) patients and A+E+V in 13/67 (19.4%) patients. CONCLUSIONS: PMR presents by articular/periarticular synovitis, extraarticular synovitis and can be accompanied by giant cell arteritis. All types of involvement have their distinct FDG PET (PET/CT) finding, which can be seen either individually or in any of their 4 combinations. FDG PET (PET/CT) examination seems to be an advantageous one-step examination for detecting different variants of PMR, for assessing extent and severity and also for excluding occult malignancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17004322
003      
CZ-PrNML
005      
20170308085104.0
007      
ta
008      
170127s2015 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2015.026 $2 doi
024    7_
$a 10.5507/bp.2015.026 $2 doi
035    __
$a (PubMed)26006092
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Řehák, Zdeněk $u Department of Nuclear Medicine and PET Center, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Regional Center of Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute Brno $7 xx0101561
245    10
$a Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica / $c Z. Rehak, J. Vasina, P. Nemec, Z. Fojtik, R. Koukalova, Z. Bortlicek, D. Rehakova, J. Adam, A. Vavrusova, Z. Adam
520    9_
$a AIM: Polymyalgia rheumatica (PMR) is a disease presenting with pain and stiffness, mainly in shoulders, hip joints and neck. Laboratory markers of inflammation may bolster diagnosis. PMR afflicts patients over 50 years old, predominantly women, and may also accompany giant cell arteritis. PATIENTS AND METHODS: 67 patients, who fullfiled Healey´s criteria for PMR in the period between 2004 and 2013 and had positive FDG PET (PET/CT) findings were retrospectively evaluated. FDG uptake was assessed in large arteries, proximal joints (shoulders, hips and sternoclavicular joints), in extraarticular synovial structures (interspinous, ischiogluteal and praepubic bursae). RESULTS: Articular/periarticular involvement (A) was detected in 59/67 (88.1%) patients and extrarticular synovial involvement (E) in 51/67 (76.1%) patients either individually or in combinations. Vascular involvement (V) was detected in 27/67 (40.3%) patients only in combination with articular (A) and/or extraarticular synovial (E) involvement. These combinations were: A+E involvement in 30/67 (44.8%) patients, A+V involvement in 8/67 (11.9%) patients, E+V involvement in 6/67 (9%) patients and A+E+V in 13/67 (19.4%) patients. CONCLUSIONS: PMR presents by articular/periarticular synovitis, extraarticular synovitis and can be accompanied by giant cell arteritis. All types of involvement have their distinct FDG PET (PET/CT) finding, which can be seen either individually or in any of their 4 combinations. FDG PET (PET/CT) examination seems to be an advantageous one-step examination for detecting different variants of PMR, for assessing extent and severity and also for excluding occult malignancy.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a burzitida $x diagnostické zobrazování $7 D002062
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluorodeoxyglukosa F18 $7 D019788
650    _2
$a obrovskobuněčná arteritida $x diagnostické zobrazování $7 D013700
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multimodální zobrazování $x metody $7 D064847
650    _2
$a polymyalgia rheumatica $x diagnostické zobrazování $7 D011111
650    _2
$a PET/CT $x metody $7 D000072078
650    _2
$a pozitronová emisní tomografie $x metody $7 D049268
650    _2
$a radiofarmaka $7 D019275
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a synovitida $x diagnostické zobrazování $7 D013585
650    _2
$a vaskulitida $x diagnostické zobrazování $7 D014657
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vašina, Jiří $u Department of Nuclear Medicine and PET Center, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Center of Molecular Imaging, International Clinical Research Center (ICRC), St. Anne's University Hospital in Brno $7 xx0227822
700    1_
$a Němec, Petr $u Rheumatology Unit, 2nd Department of Internal Medicine, St. Anne´s University Hospital Brno and Faculty of Medicine, Masaryk University, Brno $7 xx0054143
700    1_
$a Fojtík, Zdeněk, $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno. $d 1962- $7 xx0020071
700    1_
$a Koukalová, Renata $u Department of Nuclear Medicine and PET Center, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0130184
700    1_
$a Bortlíček, Zbyněk $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno. $7 xx0194424
700    1_
$a Řeháková, Dorota, $u Department of Internal Medicine, Geriatrics and Practical Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno $d 1975- $7 xx0192116
700    1_
$a Adam, Jan $u Regional Center of Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute Brno; Radiopharmaceuticals Division, UJV Rez, a. s., Rez $7 xx0116781
700    1_
$a Vavrusova, Alena $u Department of Internal Medicine, Hospital Trebic
700    1_
$a Adam, Zdeněk, $u Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno $d 1953- $7 jn19981000018
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 4 (2015), s. 629-636
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170127 $b ABA008
991    __
$a 20170307132453 $b ABA008
999    __
$a ok $b bmc $g 1192537 $s 964938
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 159 $c 4 $d 629-636 $e 20150525 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170127

Najít záznam

Citační ukazatele

Možnosti archivace